<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2020-10-07" version="170">
<accession>O43914</accession>
<accession>A8K2X0</accession>
<accession>F5H389</accession>
<accession>Q6FGA5</accession>
<accession>Q9UMT3</accession>
<name>TYOBP_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="37">TYRO protein tyrosine kinase-binding protein</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="32">DNAX-activation protein 12</fullName>
</alternativeName>
<alternativeName>
<fullName>Killer-activating receptor-associated protein</fullName>
<shortName>KAR-associated protein</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="37">TYROBP</name>
<name type="synonym" evidence="32">DAP12</name>
<name type="synonym" evidence="5">KARAP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Nature" volume="391" first="703" last="707">
<title>Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.</title>
<authorList>
<person name="Lanier L.L."/>
<person name="Corliss B.C."/>
<person name="Wu J."/>
<person name="Leong C."/>
<person name="Phillips J.H."/>
</authorList>
<dbReference type="PubMed" id="9490415"/>
<dbReference type="DOI" id="10.1038/35642"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="2">
<citation type="submission" date="1998-08" db="EMBL/GenBank/DDBJ databases">
<title>Killer activating receptor associated protein isoform b.</title>
<authorList>
<person name="Cantoni C."/>
<person name="Biassoni R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Lymphoid tissue</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2002-01" db="EMBL/GenBank/DDBJ databases">
<title>Dendritic cells express two types of immunoreceptor DAP12 transcripts.</title>
<authorList>
<person name="Begum N.A."/>
<person name="Seya T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Genome Res." volume="16" first="55" last="65">
<title>Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.</title>
<authorList>
<person name="Kimura K."/>
<person name="Wakamatsu A."/>
<person name="Suzuki Y."/>
<person name="Ota T."/>
<person name="Nishikawa T."/>
<person name="Yamashita R."/>
<person name="Yamamoto J."/>
<person name="Sekine M."/>
<person name="Tsuritani K."/>
<person name="Wakaguri H."/>
<person name="Ishii S."/>
<person name="Sugiyama T."/>
<person name="Saito K."/>
<person name="Isono Y."/>
<person name="Irie R."/>
<person name="Kushida N."/>
<person name="Yoneyama T."/>
<person name="Otsuka R."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Kondo H."/>
<person name="Wagatsuma M."/>
<person name="Murakawa K."/>
<person name="Ishida S."/>
<person name="Ishibashi T."/>
<person name="Takahashi-Fujii A."/>
<person name="Tanase T."/>
<person name="Nagai K."/>
<person name="Kikuchi H."/>
<person name="Nakai K."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="16344560"/>
<dbReference type="DOI" id="10.1101/gr.4039406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Immunity" volume="8" first="693" last="701">
<title>Association of DAP12 with activating CD94/NKG2C NK cell receptors.</title>
<authorList>
<person name="Lanier L.L."/>
<person name="Corliss B."/>
<person name="Wu J."/>
<person name="Phillips J.H."/>
</authorList>
<dbReference type="PubMed" id="9655483"/>
<dbReference type="DOI" id="10.1016/s1074-7613(00)80574-9"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KLRD1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="9792" last="9796">
<title>Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells.</title>
<authorList>
<person name="Bakker A.B.H."/>
<person name="Baker E."/>
<person name="Sutherland G.R."/>
<person name="Phillips J.H."/>
<person name="Lanier L.L."/>
</authorList>
<dbReference type="PubMed" id="10449773"/>
<dbReference type="DOI" id="10.1073/pnas.96.17.9792"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CLECSF5</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="9" last="12">
<title>Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells.</title>
<authorList>
<person name="Dietrich J."/>
<person name="Cella M."/>
<person name="Seiffert M."/>
<person name="Buehring H.-J."/>
<person name="Colonna M."/>
</authorList>
<dbReference type="PubMed" id="10604985"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.1.9"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SIRPB1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="357" last="361">
<title>Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.</title>
<authorList>
<person name="Paloneva J."/>
<person name="Kestilae M."/>
<person name="Wu J."/>
<person name="Salminen A."/>
<person name="Boehling T."/>
<person name="Ruotsalainen V."/>
<person name="Hakola P."/>
<person name="Bakker A.B.H."/>
<person name="Phillips J.H."/>
<person name="Pekkarinen P."/>
<person name="Lanier L.L."/>
<person name="Timonen T."/>
<person name="Peltonen L."/>
</authorList>
<dbReference type="PubMed" id="10888890"/>
<dbReference type="DOI" id="10.1038/77153"/>
</citation>
<scope>INVOLVEMENT IN PLOSL1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="4991" last="4995">
<title>Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.</title>
<authorList>
<person name="Bouchon A."/>
<person name="Dietrich J."/>
<person name="Colonna M."/>
</authorList>
<dbReference type="PubMed" id="10799849"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.10.4991"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TREM1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Exp. Med." volume="194" first="1111" last="1122">
<title>A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.</title>
<authorList>
<person name="Bouchon A."/>
<person name="Hernandez-Munain C."/>
<person name="Cella M."/>
<person name="Colonna M."/>
</authorList>
<dbReference type="PubMed" id="11602640"/>
<dbReference type="DOI" id="10.1084/jem.194.8.1111"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TREM2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Neurology" volume="59" first="1105" last="1107">
<title>Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms.</title>
<authorList>
<person name="Kondo T."/>
<person name="Takahashi K."/>
<person name="Kohara N."/>
<person name="Takahashi Y."/>
<person name="Hayashi S."/>
<person name="Takahashi H."/>
<person name="Matsuo H."/>
<person name="Yamazaki M."/>
<person name="Inoue K."/>
<person name="Miyamoto K."/>
<person name="Yamamura T."/>
</authorList>
<dbReference type="PubMed" id="12370476"/>
<dbReference type="DOI" id="10.1212/wnl.59.7.1105"/>
</citation>
<scope>INVOLVEMENT IN PLOSL1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Mol. Immunol." volume="38" first="817" last="824">
<title>TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.</title>
<authorList>
<person name="Gingras M.-C."/>
<person name="Lapillonne H."/>
<person name="Margolin J.F."/>
</authorList>
<dbReference type="PubMed" id="11922939"/>
<dbReference type="DOI" id="10.1016/s0161-5890(02)00004-4"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Immunol." volume="173" first="6703" last="6711">
<title>Molecular characterization of a novel immune receptor restricted to the monocytic lineage.</title>
<authorList>
<person name="Aguilar H."/>
<person name="Alvarez-Errico D."/>
<person name="Garcia-Montero A.C."/>
<person name="Orfao A."/>
<person name="Sayos J."/>
<person name="Lopez-Botet M."/>
</authorList>
<dbReference type="PubMed" id="15557162"/>
<dbReference type="DOI" id="10.4049/jimmunol.173.11.6703"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD300E</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="FASEB J." volume="20" first="1964" last="1973">
<title>Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.</title>
<authorList>
<person name="Angata T."/>
<person name="Hayakawa T."/>
<person name="Yamanaka M."/>
<person name="Varki A."/>
<person name="Nakamura M."/>
</authorList>
<dbReference type="PubMed" id="17012248"/>
<dbReference type="DOI" id="10.1096/fj.06-5800com"/>
</citation>
<scope>INTERACTION WITH SIGLEC14</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="J. Immunol." volume="177" first="2819" last="2830">
<title>Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways.</title>
<authorList>
<person name="Martinez-Barriocanal A."/>
<person name="Sayos J."/>
</authorList>
<dbReference type="PubMed" id="16920917"/>
<dbReference type="DOI" id="10.4049/jimmunol.177.5.2819"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD300LB</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Blood" volume="111" first="688" last="698">
<title>Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells.</title>
<authorList>
<person name="Yamanishi Y."/>
<person name="Kitaura J."/>
<person name="Izawa K."/>
<person name="Matsuoka T."/>
<person name="Oki T."/>
<person name="Lu Y."/>
<person name="Shibata F."/>
<person name="Yamazaki S."/>
<person name="Kumagai H."/>
<person name="Nakajima H."/>
<person name="Maeda-Yamamoto M."/>
<person name="Tybulewicz V.L.J."/>
<person name="Takai T."/>
<person name="Kitamura T."/>
</authorList>
<dbReference type="PubMed" id="17928527"/>
<dbReference type="DOI" id="10.1182/blood-2007-04-085787"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD300LB</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Eur. J. Immunol." volume="38" first="2284" last="2289">
<title>Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.</title>
<authorList>
<person name="Della Chiesa M."/>
<person name="Romeo E."/>
<person name="Falco M."/>
<person name="Balsamo M."/>
<person name="Augugliaro R."/>
<person name="Moretta L."/>
<person name="Bottino C."/>
<person name="Moretta A."/>
<person name="Vitale M."/>
</authorList>
<dbReference type="PubMed" id="18624290"/>
<dbReference type="DOI" id="10.1002/eji.200838434"/>
</citation>
<scope>INTERACTION WITH KIR2DS5</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Sci. Signal." volume="1" first="RA11" last="RA11">
<title>Essential role of DAP12 signaling in macrophage programming into a fusion-competent state.</title>
<authorList>
<person name="Helming L."/>
<person name="Tomasello E."/>
<person name="Kyriakides T.R."/>
<person name="Martinez F.O."/>
<person name="Takai T."/>
<person name="Gordon S."/>
<person name="Vivier E."/>
</authorList>
<dbReference type="PubMed" id="18957693"/>
<dbReference type="DOI" id="10.1126/scisignal.1159665"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="J. Exp. Med." volume="208" first="1661" last="1671">
<title>The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses.</title>
<authorList>
<person name="Nakano-Yokomizo T."/>
<person name="Tahara-Hanaoka S."/>
<person name="Nakahashi-Oda C."/>
<person name="Nabekura T."/>
<person name="Tchao N.K."/>
<person name="Kadosaki M."/>
<person name="Totsuka N."/>
<person name="Kurita N."/>
<person name="Nakamagoe K."/>
<person name="Tamaoka A."/>
<person name="Takai T."/>
<person name="Yasui T."/>
<person name="Kikutani H."/>
<person name="Honda S."/>
<person name="Shibuya K."/>
<person name="Lanier L.L."/>
<person name="Shibuya A."/>
</authorList>
<dbReference type="PubMed" id="21727189"/>
<dbReference type="DOI" id="10.1084/jem.20101623"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Leukoc. Biol." volume="94" first="301" last="313">
<title>DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.</title>
<authorList>
<person name="Mulrooney T.J."/>
<person name="Posch P.E."/>
<person name="Hurley C.K."/>
</authorList>
<dbReference type="PubMed" id="23715743"/>
<dbReference type="DOI" id="10.1189/jlb.0213093"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KIR2DS1</scope>
<scope>MUTAGENESIS OF ASP-50</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="15866" last="15877">
<title>DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response.</title>
<authorList>
<person name="Zhong L."/>
<person name="Chen X.F."/>
<person name="Zhang Z.L."/>
<person name="Wang Z."/>
<person name="Shi X.Z."/>
<person name="Xu K."/>
<person name="Zhang Y.W."/>
<person name="Xu H."/>
<person name="Bu G."/>
</authorList>
<dbReference type="PubMed" id="25957402"/>
<dbReference type="DOI" id="10.1074/jbc.m115.645986"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TREM2</scope>
<scope>MUTAGENESIS OF ASP-50</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="22298" last="22308">
<title>Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family.</title>
<authorList>
<person name="Niizuma K."/>
<person name="Tahara-Hanaoka S."/>
<person name="Noguchi E."/>
<person name="Shibuya A."/>
</authorList>
<dbReference type="PubMed" id="26221034"/>
<dbReference type="DOI" id="10.1074/jbc.m115.643361"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD300H</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="1023" last="1029">
<title>The structural basis for intramembrane assembly of an activating immunoreceptor complex.</title>
<authorList>
<person name="Call M.E."/>
<person name="Wucherpfennig K.W."/>
<person name="Chou J.J."/>
</authorList>
<dbReference type="PubMed" id="20890284"/>
<dbReference type="DOI" id="10.1038/ni.1943"/>
</citation>
<scope>STRUCTURE BY NMR OF 35-67 IN COMPLEX WITH KLRC2</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BOND</scope>
<scope>MUTAGENESIS OF THR-54</scope>
<scope>INTERACTION WITH KLRC2 AND KIR2DS3</scope>
</reference>
<reference key="31" evidence="3 4">
<citation type="journal article" date="2015" name="Cell Rep." volume="11" first="1184" last="1192">
<title>Transmembrane complexes of DAP12 crystallized in lipid membranes provide insights into control of oligomerization in immunoreceptor assembly.</title>
<authorList>
<person name="Knoblich K."/>
<person name="Park S."/>
<person name="Lutfi M."/>
<person name="van 't Hag L."/>
<person name="Conn C.E."/>
<person name="Seabrook S.A."/>
<person name="Newman J."/>
<person name="Czabotar P.E."/>
<person name="Im W."/>
<person name="Call M.E."/>
<person name="Call M.J."/>
</authorList>
<dbReference type="PubMed" id="25981043"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.04.045"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 35-67</scope>
<scope>SUBUNIT</scope>
<scope>TRANSMEMBRANE DOMAIN</scope>
<scope>METAL-BINDING</scope>
<scope>DISULFIDE BOND</scope>
<scope>MUTAGENESIS OF GLY-41; GLY-45; GLY-49; ASP-50 AND THR-54</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2016" name="Neurobiol. Aging" volume="48" first="222.E9" last="222.E15">
<title>TYROBP genetic variants in early-onset Alzheimer's disease.</title>
<authorList>
<person name="Pottier C."/>
<person name="Ravenscroft T.A."/>
<person name="Brown P.H."/>
<person name="Finch N.A."/>
<person name="Baker M."/>
<person name="Parsons M."/>
<person name="Asmann Y.W."/>
<person name="Ren Y."/>
<person name="Christopher E."/>
<person name="Levitch D."/>
<person name="van Blitterswijk M."/>
<person name="Cruchaga C."/>
<person name="Campion D."/>
<person name="Nicolas G."/>
<person name="Richard A.C."/>
<person name="Guerreiro R."/>
<person name="Bras J.T."/>
<person name="Zuchner S."/>
<person name="Gonzalez M.A."/>
<person name="Bu G."/>
<person name="Younkin S."/>
<person name="Knopman D.S."/>
<person name="Josephs K.A."/>
<person name="Parisi J.E."/>
<person name="Petersen R.C."/>
<person name="Ertekin-Taner N."/>
<person name="Graff-Radford N.R."/>
<person name="Boeve B.F."/>
<person name="Dickson D.W."/>
<person name="Rademakers R."/>
</authorList>
<dbReference type="PubMed" id="27658901"/>
<dbReference type="DOI" id="10.1016/j.neurobiolaging.2016.07.028"/>
</citation>
<scope>VARIANTS GLU-2; CYS-23; ALA-47; PRO-ALA-ASP-GLY-ARG-LEU-VAL-LEU-GLY-ASP-ARG-ASP-GLY-ARG-50 INS; LEU-55; TRP-80; VAL-84 AND LEU-89</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="Neurobiol. Aging" volume="58" first="240.E1" last="240.E3">
<title>Mutations in TYROBP are not a common cause of dementia in a Turkish cohort.</title>
<authorList>
<person name="Darwent L."/>
<person name="Carmona S."/>
<person name="Lohmann E."/>
<person name="Guven G."/>
<person name="Kun-Rodrigues C."/>
<person name="Bilgic B."/>
<person name="Hanagasi H."/>
<person name="Gurvit H."/>
<person name="Erginel-Unaltuna N."/>
<person name="Pak M."/>
<person name="Hardy J."/>
<person name="Singleton A."/>
<person name="Bras J."/>
<person name="Guerreiro R."/>
</authorList>
<dbReference type="PubMed" id="28716534"/>
<dbReference type="DOI" id="10.1016/j.neurobiolaging.2017.06.019"/>
</citation>
<scope>VARIANT LEU-55</scope>
</reference>
<comment type="function">
<text evidence="5 7 8 9 11 14 15 17 19 21 22 23 25 28 29">Adapter protein which non-covalently associates with activating receptors found on the surface of a variety of immune cells to mediate signaling and cell activation following ligand binding by the receptors (PubMed:9490415, PubMed:9655483, PubMed:10604985). TYROBP is tyrosine-phosphorylated in the ITAM domain following ligand binding by the associated receptors which leads to activation of additional tyrosine kinases and subsequent cell activation (PubMed:9490415). Also has an inhibitory role in some cells (PubMed:21727189). Non-covalently associates with activating receptors of the CD300 family to mediate cell activation (PubMed:15557162, PubMed:16920917, PubMed:17928527; PubMed:26221034). Also mediates cell activation through association with activating receptors of the CD200R family (By similarity). Required for neutrophil activation mediated by integrin (By similarity). Required for the activation of myeloid cells mediated by the CLEC5A/MDL1 receptor (PubMed:10449773). Associates with natural killer (NK) cell receptors such as KIR2DS2 and the KLRD1/KLRC2 heterodimer to mediate NK cell activation (PubMed:9490415, PubMed:9655483, PubMed:23715743). Also enhances trafficking and cell surface expression of NK cell receptors KIR2DS1, KIR2DS2 and KIR2DS4 and ensures their stability at the cell surface (PubMed:23715743). Associates with SIRPB1 to mediate activation of myeloid cells such as monocytes and dendritic cells (PubMed:10604985). Associates with TREM1 to mediate activation of neutrophils and monocytes (PubMed:10799849). Associates with TREM2 on monocyte-derived dendritic cells to mediate up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival (PubMed:11602640). Association with TREM2 mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (PubMed:18957693). Stabilizes the TREM2 C-terminal fragment (TREM2-CTF) produced by TREM2 ectodomain shedding which suppresses the release of pro-inflammatory cytokines (PubMed:25957402). In microglia, required with TREM2 for phagocytosis of apoptotic neurons (By similarity). Required with ITGAM/CD11B in microglia to control production of microglial superoxide ions which promote the neuronal apoptosis that occurs during brain development (By similarity). Promotes proinflammatory responses in microglia following nerve injury which accelerates degeneration of injured neurons (By similarity). Positively regulates the expression of the IRAK3/IRAK-M kinase and IL10 production by liver dendritic cells and inhibits their T cell allostimulatory ability (By similarity). Negatively regulates B cell proliferation (PubMed:21727189). Required for CSF1-mediated osteoclast cytoskeletal organization (By similarity). Positively regulates multinucleation during osteoclast development (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="5 7 8 9 11 14 15 16 17 18 20 22 23 24 25 29">Homodimer; disulfide-linked (PubMed:20890284). Homotrimer; disulfide-linked (PubMed:25981043). Homotetramer; disulfide-linked (PubMed:25981043). Homotrimers and homotetramers form when low levels of partner receptors are available and are competitive with assembly with interacting receptors (PubMed:25981043). They may represent alternative oligomerization states or may be intermediates in the receptor assembly process (PubMed:25981043). Binding of a metal cation aids in homooligomerization through coordination of the metal ion by the subunits of the oligomer (PubMed:25981043). Interacts with TREM1 (PubMed:10799849). Interacts with TREM2 (PubMed:11602640, PubMed:25957402). Interacts with SIRPB1 (PubMed:10604985). Interacts with CLECSF5 (PubMed:10449773). Interacts with SIGLEC14 (PubMed:17012248). Interacts with CD300LB and CD300E (PubMed:15557162, PubMed:16920917, PubMed:17928527). Interacts with CD300C2 (By similarity). Interacts (via ITAM domain) with SYK (via SH2 domains); activates SYK mediating neutrophil and macrophage integrin-mediated activation (By similarity). Interacts with KLRC2, KIR2DS3 and KIR2DS5 (PubMed:18624290, PubMed:20890284). Interacts with CD300H (PubMed:26221034). Interacts with KIR2DS1 (PubMed:23715743). Interacts with KLRD1 (PubMed:9655483).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-16823921">
<id>Q14953</id>
<label>KIR2DS5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-14058375">
<id>O95944</id>
<label>NCR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-2615458">
<id>O00241</id>
<label>SIRPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-10281213">
<id>Q969S0</id>
<label>SLC35B4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-12015604">
<id>Q8N2M4</id>
<label>TMEM86A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-14036387">
<id>Q9NZC2</id>
<label>TREM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2214794">
<id>O43914</id>
</interactant>
<interactant intactId="EBI-2214794">
<id>O43914</id>
<label>TYROBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29">Cell membrane</location>
<topology evidence="6">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43914-1</id>
<name>1</name>
<name>KARAP-a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43914-2</id>
<name>2</name>
<name>KARAP-b</name>
<sequence type="described" ref="VSP_012909"/>
</isoform>
<isoform>
<id>O43914-3</id>
<name>3</name>
<sequence type="described" ref="VSP_046066"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="12">Expressed at low levels in the early development of the hematopoietic system and in the promonocytic stage and at high levels in mature monocytes. Expressed in hematological cells and tissues such as peripheral blood leukocytes and spleen. Also found in bone marrow, lymph nodes, placenta, lung and liver. Expressed at lower levels in different parts of the brain especially in the basal ganglia and corpus callosum.</text>
</comment>
<comment type="PTM">
<text evidence="28">Following ligand binding by associated receptors, tyrosine phosphorylated in the ITAM domain which leads to activation of additional tyrosine kinases and subsequent cell activation.</text>
</comment>
<comment type="disease" evidence="10 13">
<disease id="DI-02174">
<name>Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1</name>
<acronym>PLOSL1</acronym>
<description>A recessively inherited disease characterized by presenile dementia along with large-scale destruction of cancellous bones. Initial symptoms, starting in the twenties, are pain and swelling resulting from cysts in the wrists and ankles. Extremity bone fractures could occur with minor trauma. At around 30 years of age, patients gradually develop neuropsychiatric symptoms, including epileptic seizures, agnosia, apraxia, speech disorder, memory disturbance, euphoria, and loss of social inhibitions. The disorder usuallly leads to death in the fifth decade of life.</description>
<dbReference type="MIM" id="221770"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the TYROBP family.</text>
</comment>
<dbReference type="EMBL" id="AF019562">
<property type="protein sequence ID" value="AAD09436.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF019563">
<property type="protein sequence ID" value="AAD09437.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ010098">
<property type="protein sequence ID" value="CAB52288.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY074782">
<property type="protein sequence ID" value="AAL74017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009851">
<property type="protein sequence ID" value="AAP88853.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290385">
<property type="protein sequence ID" value="BAF83074.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR450342">
<property type="protein sequence ID" value="CAG29338.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542202">
<property type="protein sequence ID" value="CAG46999.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BP295666">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AD000833">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AD000864">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011175">
<property type="protein sequence ID" value="AAH11175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12482.1">
<molecule id="O43914-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46058.1">
<molecule id="O43914-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54255.1">
<molecule id="O43914-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001166985.1">
<molecule id="O43914-3"/>
<property type="nucleotide sequence ID" value="NM_001173514.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003323.1">
<molecule id="O43914-1"/>
<property type="nucleotide sequence ID" value="NM_003332.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_937758.1">
<molecule id="O43914-2"/>
<property type="nucleotide sequence ID" value="NM_198125.2"/>
</dbReference>
<dbReference type="PDB" id="2L34">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=35-67"/>
</dbReference>
<dbReference type="PDB" id="2L35">
<property type="method" value="NMR"/>
<property type="chains" value="A=35-67, B=35-66"/>
</dbReference>
<dbReference type="PDB" id="4WO1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.14"/>
<property type="chains" value="A/B/C/D=35-67"/>
</dbReference>
<dbReference type="PDB" id="4WOL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A/B/C=35-67"/>
</dbReference>
<dbReference type="PDBsum" id="2L34"/>
<dbReference type="PDBsum" id="2L35"/>
<dbReference type="PDBsum" id="4WO1"/>
<dbReference type="PDBsum" id="4WOL"/>
<dbReference type="SMR" id="O43914"/>
<dbReference type="BioGRID" id="113155">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="CORUM" id="O43914"/>
<dbReference type="IntAct" id="O43914">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000262629"/>
<dbReference type="TCDB" id="8.A.128.1.1">
<property type="family name" value="the signaling adaptor protein karap/dap12/tyrobp (sap) family"/>
</dbReference>
<dbReference type="iPTMnet" id="O43914"/>
<dbReference type="PhosphoSitePlus" id="O43914"/>
<dbReference type="BioMuta" id="TYROBP"/>
<dbReference type="EPD" id="O43914"/>
<dbReference type="jPOST" id="O43914"/>
<dbReference type="MassIVE" id="O43914"/>
<dbReference type="PaxDb" id="O43914"/>
<dbReference type="PeptideAtlas" id="O43914"/>
<dbReference type="PRIDE" id="O43914"/>
<dbReference type="ProteomicsDB" id="26198"/>
<dbReference type="ProteomicsDB" id="49229">
<molecule id="O43914-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49230">
<molecule id="O43914-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="4010">
<property type="antibodies" value="290 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7305"/>
<dbReference type="Ensembl" id="ENST00000262629">
<molecule id="O43914-1"/>
<property type="protein sequence ID" value="ENSP00000262629"/>
<property type="gene ID" value="ENSG00000011600"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000544690">
<molecule id="O43914-3"/>
<property type="protein sequence ID" value="ENSP00000445332"/>
<property type="gene ID" value="ENSG00000011600"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000589517">
<molecule id="O43914-2"/>
<property type="protein sequence ID" value="ENSP00000468447"/>
<property type="gene ID" value="ENSG00000011600"/>
</dbReference>
<dbReference type="GeneID" id="7305"/>
<dbReference type="KEGG" id="hsa:7305"/>
<dbReference type="UCSC" id="uc002ocm.4">
<molecule id="O43914-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7305"/>
<dbReference type="DisGeNET" id="7305"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000011600.11"/>
<dbReference type="GeneCards" id="TYROBP"/>
<dbReference type="GeneReviews" id="TYROBP"/>
<dbReference type="HGNC" id="HGNC:12449">
<property type="gene designation" value="TYROBP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000011600">
<property type="expression patterns" value="Tissue enhanced (blood, bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="TYROBP"/>
<dbReference type="MIM" id="221770">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604142">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43914"/>
<dbReference type="OpenTargets" id="ENSG00000011600"/>
<dbReference type="Orphanet" id="2770">
<property type="disease" value="Nasu-Hakola disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37100"/>
<dbReference type="eggNOG" id="ENOG502SCVI">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000016786"/>
<dbReference type="HOGENOM" id="CLU_141718_0_0_1"/>
<dbReference type="InParanoid" id="O43914"/>
<dbReference type="KO" id="K07992"/>
<dbReference type="OrthoDB" id="1508977at2759"/>
<dbReference type="PhylomeDB" id="O43914"/>
<dbReference type="TreeFam" id="TF336898"/>
<dbReference type="PathwayCommons" id="O43914"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2172127">
<property type="pathway name" value="DAP12 interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-391160">
<property type="pathway name" value="Signal regulatory protein family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416700">
<property type="pathway name" value="Other semaphorin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="SignaLink" id="O43914"/>
<dbReference type="BioGRID-ORCS" id="7305">
<property type="hits" value="7 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TYROBP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O43914"/>
<dbReference type="GeneWiki" id="TYROBP"/>
<dbReference type="GenomeRNAi" id="7305"/>
<dbReference type="Pharos" id="O43914">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O43914"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="O43914">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000011600">
<property type="expression patterns" value="Expressed in blood and 230 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O43914">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43914">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030667">
<property type="term" value="C:secretory granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030036">
<property type="term" value="P:actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043277">
<property type="term" value="P:apoptotic cell clearance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030900">
<property type="term" value="P:forebrain development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002282">
<property type="term" value="P:microglial cell activation involved in immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002274">
<property type="term" value="P:myeloid leukocyte activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032693">
<property type="term" value="P:negative regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900272">
<property type="term" value="P:negative regulation of long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032911">
<property type="term" value="P:negative regulation of transforming growth factor beta1 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002283">
<property type="term" value="P:neutrophil activation involved in immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030316">
<property type="term" value="P:osteoclast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0110090">
<property type="term" value="P:positive regulation of hippocampal neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034241">
<property type="term" value="P:positive regulation of macrophage fusion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904151">
<property type="term" value="P:positive regulation of microglial cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032816">
<property type="term" value="P:positive regulation of natural killer cell activation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001206">
<property type="term" value="P:positive regulation of osteoclast development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000010">
<property type="term" value="P:positive regulation of protein localization to cell surface"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902685">
<property type="term" value="P:positive regulation of receptor localization to synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042535">
<property type="term" value="P:positive regulation of tumor necrosis factor biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048678">
<property type="term" value="P:response to axon injury"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR026200">
<property type="entry name" value="Tyrobp"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR17554">
<property type="entry name" value="PTHR17554"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="TYRO protein tyrosine kinase-binding protein" id="PRO_0000022603">
<location>
<begin position="22"/>
<end position="113"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="36">
<location>
<begin position="22"/>
<end position="40"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="24">
<location>
<begin position="41"/>
<end position="61"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="62"/>
<end position="113"/>
</location>
</feature>
<feature type="domain" description="ITAM">
<location>
<begin position="80"/>
<end position="108"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Metal cation; shared with neighboring subunit in homooligomer" evidence="24">
<location>
<position position="50"/>
</location>
</feature>
<feature type="site" description="Important for interaction with transmembrane receptors" evidence="20">
<location>
<position position="54"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="91"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="102"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="1 2 4 20 24">
<location>
<position position="35"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046066" evidence="31">
<location>
<begin position="20"/>
<end position="30"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_012909" evidence="30 33 34">
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; associated in cis with L-55 in some patients; dbSNP:rs200649978." id="VAR_081398" evidence="26">
<original>G</original>
<variation>E</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; dbSNP:rs769635655." id="VAR_081399" evidence="26">
<original>R</original>
<variation>C</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; dbSNP:rs372140827." id="VAR_081400" evidence="26">
<original>V</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; causes reduced expression; also leads to reduced expression of TREM2." id="VAR_081401" evidence="26">
<original>D</original>
<variation>DPADGRLVLGDRDGR</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; associated in cis with E-2 in some patients; dbSNP:rs77782321." id="VAR_081402" evidence="26 27">
<original>V</original>
<variation>L</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; dbSNP:rs140188939." id="VAR_081403" evidence="26">
<original>R</original>
<variation>W</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance." id="VAR_081404" evidence="26">
<original>I</original>
<variation>V</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with early-onset Alzheimer disease; unknown pathological significance; dbSNP:rs557854792." id="VAR_081405" evidence="26">
<original>S</original>
<variation>L</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs14714." id="VAR_011985">
<original>Y</original>
<variation>H</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not significantly alter the formation of homotrimers or homotetramers; when associated with L-45 and L-49." evidence="24">
<original>G</original>
<variation>L</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not significantly alter the formation of homotrimers or homotetramers; when associated with L-41 and L-49." evidence="24">
<original>G</original>
<variation>L</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not significantly alter the formation of homotrimers or homotetramers; when associated with L-41 and L-45." evidence="24">
<original>G</original>
<variation>L</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced cell surface expression of KIR2DS1. Severely impairs formation of homotrimers and homotetramers. Abolishes interaction with TREM2 and stabilization of TREM2-CTF." evidence="22 23 24">
<original>D</original>
<variation>A</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severely impairs formation of homotrimers and homotetramers." evidence="24">
<original>D</original>
<variation>E</variation>
<variation>Q</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces formation of homotrimers and homotetramers." evidence="24">
<original>D</original>
<variation>N</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with KLRC2 and KIR2DS3. Reduces homotrimer formation and increases homotetramer formation." evidence="20 24">
<original>T</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="40"/>
<end position="65"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L34"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L35"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WO1"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WOL"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O54885"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10449773"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10604985"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10799849"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10888890"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11602640"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11922939"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12370476"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15557162"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16920917"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17012248"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17928527"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18624290"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18957693"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20890284"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21727189"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23715743"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25957402"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25981043"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26221034"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27658901"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28716534"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9490415"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9655483"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16344560"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9490415"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25981043"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:12449"/>
</source>
</evidence>
<sequence length="113" mass="12179" checksum="267CB1C1756F89F0" modified="1998-06-01" version="1" precursor="true">MGGLEPCSRLLLLPLLLAVSGLRPVQAQAQSDCSCSTVSPGVLAGIVMGDLVLTVLIALAVYFLGRLVPRGRGAAEAATRKQRITETESPYQELQGQRSDVYSDLNTQRPYYK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

